Diamond Hill Capital Management
ALDR

Diamond Hill Capital Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Diamond Hill Capital Management’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-16,173
Closed -$305K – 166
2019
Q3 		$305K Buy
16,173
+5,500
+52% +$62.9K ﹤0.01% 152
2019
Q2 		$126K Buy
+10,673
New +$129K ﹤0.01% 164

Diamond Hill Capital Management's ALDR Position: Q4 2019 in Review

Diamond Hill Capital Management sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 16,173 shares — an estimated $305K sold.

Diamond Hill Capital Management first reported a position in ALDR in Q2 2019 and held it in 2 quarters. The position peaked at $305K in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

  • Diamond Hill Capital Management reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Diamond Hill Capital Management sold 16,173 Alder Biopharmaceuticals shares in Q4 2019, an estimated $305K.
  • Diamond Hill Capital Management first reported a position in Alder Biopharmaceuticals in Q2 2019 and held it in 2 quarters.
  • Diamond Hill Capital Management's Alder Biopharmaceuticals position peaked at $305K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Diamond Hill Capital Management's 13F filing for Q4 2019, filed 7 Feb 2020.